SCHEMBL3135445

SCHEMBL3135445

Cc1ccccc1-c1cccc(C(N)=O)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.53
BCAT2 O15382 1/20 0.48
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 4/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
IKBKB O14920 1/20 0.43
BTK Q06187 2/20 0.41
METAP2 P50579 1/20 0.41
PARP1 P09874 2/20 0.41
GAA P10253 1/20 0.41
BRD4 O60885 1/20 0.41
SLC9A1 P19634 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30471810 0.90 BCAT2 (0.52) MYCBCAT2KEAP1NFE2L2ALDH1A1
Trifluoroacetic Acid SCHEMBL5067779 0.89 MYC (0.47) MYCBCAT2KEAP1NFE2L2ALDH1A1
Hydrochloric Acid SCHEMBL18138748 0.89 MYC (0.49) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL1788703 0.86 BCAT2 (0.59) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL5742619 0.85 MYC (0.53) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL28512961 0.85 BCAT2 (0.53) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL6389895 0.84 KDM4E (0.57) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL3701689 0.84 MYC (0.51) MYCBCAT2KEAP1NFE2L2ALDH1A1
SCHEMBL5720757 0.83 MYC (0.65) MYCALDH1A1HPGDLMNAL3MBTL1
SCHEMBL28471957 0.83 MYC (0.59) MYCBCAT2KEAP1NFE2L2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010051237-A1 2,5-DISUBSTITUTED PHENYL CARBOXAMIDE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-05-06 WO claimed
WO-2021065893-A1 TETRALIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF 国立大学法人 筑波大学 2021-04-08 WO disclosed
EP-3154979-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF THE GABAA RECEPTOR ACTIVITY. Pfizer Limited (GB) 2017-04-19 EP disclosed
WO-2015189744-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF THE GABAA RECEPTOR ACTIVITY. PFIZER LIMITED (GB) 2015-12-17 WO disclosed